Literature DB >> 7951101

HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation.

C A Keever1, N Leong, I Cunningham, E A Copelan, B R Avalos, J Klein, N Kapoor, P W Adams, C G Orosz, P J Tutschka.   

Abstract

We describe the recipient of a marrow graft from an HLA-serologically identical unrelated donor from whom highly potent host-reactive CTL of donor origin were isolated in association with acute GVHD. Extensive sequence and biochemical analysis of the HLA complex of this donor and recipient revealed several disparities in class I and class II HLA with the potential to be recognized by T cells from the donor or the host. The donor-derived CTL exclusively recognized a class I HLA difference associated with HLA-B44. Nucleotide sequencing of donor and recipient cells revealed that the patient possessed the HLA-B*4402 allele recognized by IEF as B44.2 while the donor possessed HLA-B*4403 (IEF variant B44.1). These alleles differ at one amino acid residue located at position 156 in the alpha 2 domain. The donor-derived CTL were shown to be specific for B44.2 by blocking studies and by the lysis of five different B44.2+ unrelated cell lines, two of which were confirmed by sequencing to be homozygous for B*4402. A host-specific difference involving a HLA-DRB1 allele was not recognized by the CTL, neither did HLA differences unique to the donor HLA-B*4403 and HLA-DQ8 elicit a host response. These data show that certain HLA disparities may be tolerated at the same time that other disparities elicit a potent immunologic response. The chemical nature of the difference, its structural impact, as well as the conditions of transplant appear to influence the type of response which occurs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7951101

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  16 in total

1.  Position 45 influences the peptide binding motif of HLA-B*44:08.

Authors:  Soumya Badrinath; Trevor Huyton; Heike Schumacher; Rainer Blasczyk; Christina Bade-Doeding
Journal:  Immunogenetics       Date:  2011-10-19       Impact factor: 2.846

Review 2.  Genetics of graft-versus-host disease: the major histocompatibility complex.

Authors:  Effie W Petersdorf
Journal:  Blood Rev       Date:  2012-11-20       Impact factor: 8.250

3.  HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States.

Authors:  Lee Ann Baxter-Lowe; Martin Maiers; Stephen R Spellman; Michael D Haagenson; Tao Wang; Marcelo Fernandez-Vina; Steven G E Marsh; Mary Horowitz; Carolyn Katovich Hurley
Journal:  Biol Blood Marrow Transplant       Date:  2009-08       Impact factor: 5.742

4.  Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task.

Authors:  S R Marino; S M Lee; T A Binkowski; T Wang; M Haagenson; H-L Wang; M Maiers; S Spellman; K van Besien; S J Lee; T Karrison; A Artz
Journal:  Bone Marrow Transplant       Date:  2016-05-23       Impact factor: 5.483

5.  Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation.

Authors:  S R Marino; S Lin; M Maiers; M Haagenson; S Spellman; J P Klein; T A Binkowski; S J Lee; K van Besien
Journal:  Bone Marrow Transplant       Date:  2011-03-28       Impact factor: 5.483

6.  A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA-A(*)24 Allotypes.

Authors:  Soumya Badrinath; Heike Kunze-Schumacher; Rainer Blasczyk; Trevor Huyton; Christina Bade-Doeding
Journal:  J Immunol Res       Date:  2014-12-04       Impact factor: 4.818

7.  Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition.

Authors:  Julia K Archbold; Whitney A Macdonald; Stephanie Gras; Lauren K Ely; John J Miles; Melissa J Bell; Rebekah M Brennan; Travis Beddoe; Matthew C J Wilce; Craig S Clements; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

8.  Cross-reactive anti-viral T cells increase prior to an episode of viral reactivation post human lung transplantation.

Authors:  Thi H O Nguyen; Glen P Westall; Tara E Bull; Aislin C Meehan; Nicole A Mifsud; Tom C Kotsimbos
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

9.  A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.

Authors:  J Herman; P van der Bruggen; I F Luescher; S Mandruzzato; P Romero; J Thonnard; K Fleischhauer; T Boon; P G Coulie
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

10.  A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition.

Authors:  Whitney A Macdonald; Anthony W Purcell; Nicole A Mifsud; Lauren K Ely; David S Williams; Linus Chang; Jeffrey J Gorman; Craig S Clements; Lars Kjer-Nielsen; David M Koelle; Scott R Burrows; Brian D Tait; Rhonda Holdsworth; Andrew G Brooks; George O Lovrecz; Louis Lu; Jamie Rossjohn; James McCluskey
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.